Literature DB >> 20978000

Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-06.

F Ansari1, H Molana, H Goossens, P Davey.   

Abstract

OBJECTIVES: Our objective was to develop and test standardized methods for collection and statistical analysis of longitudinal data on hospital antibacterial use from different countries.
METHODS: We collected data on monthly supply of antibiotics from pharmacies in one hospital from each of 18 European countries. We applied a standardized method to classify drugs, measure use in defined daily doses and compare the effect of using occupied bed-days (OBDs) or admissions as denominators for longitudinal analysis.
RESULTS: Antibiotic use increased in 14 (78%) hospitals and decreased in 4 hospitals. For 16 (89%) hospitals, adjustment of antibiotic use with OBDs resulted in larger changes over time than adjustment with admissions. Inclusion of all hospital clinical activity variables (admissions, length of stay and OBDs) in multivariate time series analysis identified distinct hospital groups. Nine (50%) hospitals had statistically significant changes in antibiotic use (six increasing and three decreasing) that were not explained (n = 3) or only partially explained (n = 6) by change in clinical activity. Three (17%) hospitals had no significant change in antibiotic use. In the remaining six hospitals, apparent changes in antibiotic use were largely explained by changes in clinical activity.
CONCLUSIONS: This is the first study to use a standardized method for data collection and longitudinal analysis of antibiotic use in different hospitals. These data suggest that determination of changes in antibiotic exposure of hospital patients over a period of time is unreliable if only one clinical activity variable (such as OBDs) is used as the denominator. We recommend inclusion of admissions, OBDs and length of stay in statistical, time series analysis of antibiotic use. This model is also relevant to longitudinal analysis of infections in hospitals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978000     DOI: 10.1093/jac/dkq378

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.

Authors:  Peter Zarb; Herman Goossens
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

2.  Surveillance of broad-spectrum antibiotic prescription in Singaporean hospitals: a 5-year longitudinal study.

Authors:  Yi-Xin Liew; Prabha Krishnan; Chay-Leng Yeo; Thean-Yen Tan; Siok-Ying Lee; Wan-Peng Lim; Winnie Lee; Li-Yang Hsu
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

3.  Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results.

Authors:  Jon Birger Haug; Dag Berild; Mette Walberg; Åsmund Reikvam
Journal:  Antimicrob Resist Infect Control       Date:  2014-12-24       Impact factor: 4.887

4.  Why infectious diseases.

Authors:  John G Bartlett
Journal:  Clin Infect Dis       Date:  2014-09-15       Impact factor: 9.079

5.  Antibiotic consumption in Belgian acute care hospitals: analysis of the surveillance methodology, consumption evolution 2003 to 2016 and future perspectives.

Authors:  Eline Vandael; Koen Magerman; Samuel Coenen; Herman Goossens; Boudewijn Catry
Journal:  Euro Surveill       Date:  2019-11

6.  Implementation of an antimicrobial stewardship program on the medical-surgical service of a 100-bed community hospital.

Authors:  Donald F Storey; Perry G Pate; Autumn Tt Nguyen; Fung Chang
Journal:  Antimicrob Resist Infect Control       Date:  2012-10-09       Impact factor: 4.887

7.  Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center.

Authors:  Johannes P Borde; Klaus Kaier; Michaela Steib-Bauert; Werner Vach; Annette Geibel-Zehender; Hansjörg Busch; Hartmut Bertz; Martin Hug; Katja de With; Winfried V Kern
Journal:  BMC Infect Dis       Date:  2014-04-15       Impact factor: 3.090

8.  Emerging Infectious Diseases, Antimicrobial Resistance and Millennium Development Goals: Resolving the Challenges through One Health.

Authors:  G V Asokan; R K Kasimanickam
Journal:  Cent Asian J Glob Health       Date:  2013-10-01

9.  Observational Study of Antibiotic Usage at the Children's Clinical University Hospital in Riga, Latvia.

Authors:  Inese Sviestina; Dzintars Mozgis
Journal:  Medicina (Kaunas)       Date:  2018-10-23       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.